Amiotrófiás laterálszklerózis (ALS): vizsgálatok itt: Hollandia
15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleStudy is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 36 worldwide
- Run by
- Vector Y Therapeutics
See details and how to joinNCT07287397 · EU 2025-522697-37-00 - 1. fázisTaking peopleA Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
- Where
- Utrecht
- Életkor
- 18 év to 75 év
- People
- 36 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07100119 · EU 2025-521295-60-00 - 3. fázisTaking peoplePridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Where
- Utrecht
- Életkor
- 18 év to 80 év
- People
- 500 worldwide
- Run by
- Prilenia
See details and how to joinNCT07322003 - 1/2. fázisTaking peopleFUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS
- Where
- Utrecht
- Életkor
- 18 év to 75 év
- People
- 30 worldwide
- Run by
- Trace Neuroscience, Inc.
See details and how to joinNCT07674667 - 1/2. fázisTaking peopleA Randomized Phase 1 / 2 Trial Aiming to Restore UNC13A Function in People living with ALS: FUNCtion ALS
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 20 worldwide
- Run by
- Trace Neuroscience Inc.
See details and how to join2025-523111-11-00 - 1. fázisNot yet taking people in HollandiaA Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
- Where
- Utrecht
- Életkor
- 18 év to 80 év
- People
- 32 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07571174 - 1. fázisNot yet taking people in HollandiaA Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- Where
- Utrecht
- Életkor
- 18 év to 80 év
- People
- 32 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07571200 · EU 2026-525574-19-00 - 1/2. fázisTaking peopleA Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.
- Where
- Utrecht
- Életkor
- 18 év to 80 év
- People
- 80 worldwide
- Run by
- Nura Bio
See details and how to joinNCT07369076 - 2. fázisTaking peopleUsnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Zydus Therapeutics Inc.
See details and how to joinNCT07023835 · EU 2025-522580-15-00 - Korai 1. fázisTaking people[18F]ACI-19626 PET in TDP-43 Proteinopathies
- Where
- Amsterdam
- Életkor
- 40 év to 70 év
- People
- 45
- Run by
- AC Immune SA
See details and how to joinNCT06891716 · EU 2024-513097-21-00 - 1/2. fázisTaking peopleA Study of LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis
- Where
- Utrecht
- Életkor
- 18 év to 75 év
- People
- 56 worldwide
- Run by
- Leal Therapeutics, Inc
See details and how to joinNCT07660614 · EU 2025-522039-33-00 - 1. fázisTaking peopleResearch into the safety of a new agent (NRG5051) in healthy adults and patients with Parkinson's disease or ALS
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 118
- Run by
- Nrg Therapeutics Limited
See details and how to join2025-523872-22-00 - 3. fázisTaking peoplePridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 420 worldwide
- Run by
- Ferrer Internacional S.A.
See details and how to join2025-524002-16-00 - 2. fázisTaking peoplePsilocybin Therapy for Psychological Distress in Palliative Patients
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 108 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01 - No phaseTaking peopleInvestigation on the Cortical Communication System
- Where
- Utrecht
- Életkor
- 18 év to 70 év
- People
- 2
- Run by
- UMC Utrecht
See details and how to joinNCT06207591